Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Net Margin (2020 - 2025)

Journey Medical's Net Margin history spans 6 years, with the latest figure at 8.07% for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 2060.0% year-over-year to 8.07%, compared with a TTM value of 18.85% through Dec 2025, up 765.0%, and an annual FY2025 reading of 18.67%, up 794.0% over the prior year.
  • Net Margin for Q4 2025 was 8.07% at Journey Medical, up from 13.6% in the prior quarter.
  • The five-year high for Net Margin was 109.88% in Q3 2023, with the low at 124.17% in Q4 2021.
  • Average Net Margin over 5 years is 33.23%, with a median of 28.15% recorded in 2025.
  • Year-over-year, Net Margin crashed -14240bps in 2021 and then surged 17243bps in 2023.
  • Tracing DERM's Net Margin over 5 years: stood at 124.17% in 2021, then skyrocketed by 36bps to 80.06% in 2022, then surged by 82bps to 14.05% in 2023, then surged by 189bps to 12.54% in 2024, then plummeted by -164bps to 8.07% in 2025.
  • Per Business Quant, the three most recent readings for DERM's Net Margin are 8.07% (Q4 2025), 13.6% (Q3 2025), and 25.29% (Q2 2025).